| __timestamp | Geron Corporation | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 8901000 | 9136000 |
| Thursday, January 1, 2015 | 9574000 | 5807000 |
| Friday, January 1, 2016 | 14695000 | 5571000 |
| Sunday, January 1, 2017 | 8437000 | 5366000 |
| Monday, January 1, 2018 | 12723000 | 6337000 |
| Tuesday, January 1, 2019 | 51272000 | 11347000 |
| Wednesday, January 1, 2020 | 50052000 | 30419000 |
| Friday, January 1, 2021 | 783000 | 62176000 |
| Saturday, January 1, 2022 | 868000 | 52827000 |
| Sunday, January 1, 2023 | 123740000 | 35049000 |
Data in motion
In the competitive world of biotechnology, understanding cost structures is crucial. This analysis compares the cost of revenue for Ligand Pharmaceuticals Incorporated and Geron Corporation from 2014 to 2023. Over this period, Ligand Pharmaceuticals demonstrated a relatively stable cost structure, peaking in 2021 with a 620% increase from its 2014 figures. In contrast, Geron Corporation experienced significant fluctuations, with a dramatic 1,290% surge in 2023 compared to 2014. This volatility highlights the challenges and opportunities within the biotech sector. Notably, Geron's cost of revenue in 2023 was nearly 3.5 times that of Ligand's, reflecting strategic differences in their operational models. As the biotech industry continues to evolve, these insights provide a window into the financial dynamics that drive innovation and growth.
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Catalent, Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Geron Corporation
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Ligand Pharmaceuticals Incorporated
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Cost of Revenue: Key Insights for Alkermes plc and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Ligand Pharmaceuticals Incorporated and Geron Corporation
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored